49 results
8-K
EX-99.1
GRTS
Gritstone Bio Inc
23 Jun 21
Gritstone Announces Management Changes, Including the Appointment of Celia Economides as Chief Financial Officer
4:06pm
leadership experience in business and finance strategy, investor and corporate communications, medical affairs, and business analytics. Her expertise … , Strategy and External Affairs at Kezar Life Sciences, Inc., a public company targeting immune-mediated diseases and cancer. Before joining Kezar
8-K
EX-99.2
GRTS
Gritstone Bio Inc
4 Jan 22
Other Events
5:21pm
of a Phase 1 in HIV, collaborations surrounding our infectious disease programs, future results of operations and financial position, business strategy … volunteers previously vaccinated samRNA ChAd samRNA/samRNA U.S. SWT SWT-TCE5 150 CORAL Clinical Development Strategy Designed to Answer Key Questions
8-K
EX-99.1
GRTS
Gritstone Bio Inc
27 Sep 23
Entry into a Material Definitive Agreement
4:07pm
to discover, develop and advance product candidates into, and successfully complete, clinical trials; and our plans and strategy regarding maintaining existing
8-K
EX-99.1
GRTS
Gritstone Bio Inc
5 Mar 24
Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
4:08pm
product candidates into, and successfully complete, clinical trials; and our plans and strategy regarding maintaining existing and entering into new
424B4
GRTS
Gritstone Bio Inc
25 Apr 19
Prospectus supplement with pricing info
4:06pm
cells (bispecific antibodies), as noted above. In August 2018, we announced our collaboration supporting this strategy with bluebird bio, Inc … on vaccines, and Dr. Eugene Zhukovsky, who is an expert in the development of bispecific biotherapeutics.
Our Strategy
Our goal is to eradicate cancer
424B4
bvm0vi
1 Oct 18
Prospectus supplement with pricing info
12:00am
8-K
EX-99.1
yjf9a z1l8x
8 Nov 23
Gritstone bio Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
4:06pm
8-K
EX-99.1
34319hybo2v
9 Aug 23
Gritstone bio Reports Second Quarter 2023 Financial Results and Provides Corporate Updates
4:08pm
DRS
bghfs 23y5yb
28 Dec 18
Draft registration statement
12:00am
8-K
EX-99.1
x6wmslmjb047oz6t
9 May 24
Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates
4:07pm
8-K
EX-99.1
jkeckn wn
11 May 23
Gritstone bio Reports First Quarter 2023 Financial Results and Provides Corporate Updates
4:09pm
10-K
k18p45nt
28 Mar 19
Annual report
4:01pm
DRS/A
itbxejdvzfxm gzut99t
13 Aug 18
Draft registration statement (amended)
12:00am
DRS
uvf0 kazidb
4 May 18
Draft registration statement
12:00am
DRS/A
92hn52uix dehtje
9 Jul 18
Draft registration statement (amended)
12:00am